Neuland Laboratories Ltd - 524558 - Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025

Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Star

18113.0000 276.00 (1.55%)

NSE Nov 10, 2025 15:31 PM

Volume: 445.0K

Neuland Laboratories Ltd.

07 Nov 2025

18113.00

1.55%

Result

BSE India

Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	516.07	300.61	315.18	71.7%	63.7%
Operating Profit Qtr	155.55	34.49	62.23	351.0%	150.0%
Net Profit Qtr	96.85	13.90	32.84	596.8%	194.9%
Earning Per Share Adjusted latest Qtr	75.49	10.83	25.60	597.0%	194.9%

* Consolidated data

Detailed Results